Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for con…
Amends the VA’s Precision Medicine for Veterans Initiative to add repetitive low-level blast exposure, dementia, and other brain/mental health conditions; requires a VA–DoD data-sharing partnership and biennial reporting; mandates specific research on repetitive low-level blast exposure including big-data assessment, implementation studies, growth-hormone translational research, and quality-improvement studies; directs the VA to contract with the National Academies to validate brain biomarkers and report biennially; requires periodic assessments and authorizes $5,000,000 per year for FY2025–2030.
Narrow, low-cost, evidence-focused veterans legislation historically has a reasonable chance, though DoD cooperation and procedural timing create uncertainty.
Relative to its intended legislative type, this bill effectively amends existing law to broaden the Precision Medicine for Veterans Initiative toward precision brain health, prescribes several specific research tasks and reporting requirements, and authorizes multi-year funding, but it omits critical operational details such as data governance safeguards, detailed implementation timelines, study selection and design criteria, and cost justification.
Liberal emphasizes research benefits and biomarker validation
Liberal emphasizes research benefits and biomarker validation
Likely broadly supportive because the bill expands research and care for veterans with brain and mental health conditions and formalizes VA–DoD data sharing.
Concerned about privacy, consent, and the emphasis on growth hormone therapy without clearer safety evidence.
Pragmatic support: the bill addresses clear gaps in veteran brain-health research and improves DoD–VA coordination while being modestly funded.
Wants explicit governance, measurable outcomes, and safeguards around data security and experimental therapies.
Some guarded support for helping veterans, but significant reservations about DoD–VA data sharing, expanded federal research mandates, potential national-security exposure, and poorly justified medical interventions.
Prefers tighter limits and protections.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, low-cost, evidence-focused veterans legislation historically has a reasonable chance, though DoD cooperation and procedural timing create uncertainty.
The bill has not accumulated any surfaced votes yet.
Liberal emphasizes research benefits and biomarker validation
Narrow, low-cost, evidence-focused veterans legislation historically has a reasonable chance, though DoD cooperation and procedural timing…
Relative to its intended legislative type, this bill effectively amends existing law to broaden the Precision Medicine for Veterans Initiative toward precision brain health, prescribes several specific research tasks an…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.